Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Teleperformance: 2023 Annual Results: Profitable Growth and Strong Cash Flow: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
Teleperformance: 2023 Annual Results: Profitable Growth and Strong Cash Flow


Regulatory News:



The Board of Directors of Teleperformance, a global leader in digital business services, met today and reviewed the consolidated and parent company financial statements for the

Dassault Systèmes Unveils Innovative, Collaborative Mining Solutions from GEOVIA Within the 3DEXPERIENCE Platform at PDAC 2024: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes Unveils Innovative, Collaborative Mining Solutions from GEOVIA Within the 3DEXPERIENCE Platform at PDAC 2024


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that it is showcasing the latest portfolio advancements of its mining flagship brand GEOVIA during the Prospectors &

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Teleperformance: Press Release: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
Teleperformance: Press Release


Regulatory News:



The Teleperformance (Paris:TEP) share price has been hit hard today by a communication from a company in the financial sector announcing a high level of automation in its

Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation


Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewed its relationship with the PPD clinical research

Excellent 2023 Performance: Strong Growth and Record Earnings; Confident of Strong Growth in 2024 : https://mms.businesswire.com/media/20191119005764/en/757671/5/Colour_Logo.jpg
Excellent 2023 Performance: Strong Growth and Record Earnings; Confident of Strong Growth in 2024


Regulatory News:



2023 Key Figures1




  • Revenue of EUR 5,867.8 million for the full year 2023, up 8.5% organically and up 3.8% on a reported basis (including a positive 0.6% scope effect and a

Bureau Veritas becomes the market leader in Consumer Products Services in Mexico through the acquisition of “ANCE S.A de C.V.”, a leader in the testing and certification services for Electrical and Electronics consumer products: https://mms.businesswire.com/media/20191119005764/en/757671/5/Colour_Logo.jpg
Bureau Veritas becomes the market leader in Consumer Products Services in Mexico through the acquisition of “ANCE S.A de C.V.”, a leader in the testing and certification services for Electrical and Electronics consumer products


Bureau Veritas, a global leader in the Testing, Inspection and Certification (TIC) industry, announces the acquisition of the Conformity Assessment entity from ANCE Estándares S.C.: “ANCE S.A de

Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
 Sartorius Stedim Biotech releases Universal Registration Document 2023
Sartorius Stedim Biotech releases Universal Registration Document 2023
Sartorius Stedim Biotech releases Universal Registration Document 2023
Teleperformance Implements a New Governance Organization: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
Teleperformance Implements a New Governance Organization


Regulatory News:



At its meeting held on February 15, 2024, the Board of Directors of Teleperformance (Paris:TEP), upon recommendation of its Remuneration and Appointments Committee, unanimously

Sartorius Stedim Biotech: Information on Document Availability
Sartorius Stedim Biotech: Information on Document Availability
Sartorius Stedim Biotech: Information on Document Availability
Orange, One of the World's Leading Telecoms Operators, Has Just Published Its Full Year Results for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23780/188px-Orange_logo.svg.png
Orange, One of the World's Leading Telecoms Operators, Has Just Published Its Full Year Results for 2023


Orange, one of the world's leading telecoms operators, has just published its full year results for 2023. Christel Heydemann, CEO of Orange Group, comments on the results.



Watch video interview

Cadence and Dassault Systèmes Unveil the First Cloud-Enabled, Collaborative Experience to Transform the Development of Electromechanical Systems: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Cadence and Dassault Systèmes Unveil the First Cloud-Enabled, Collaborative Experience to Transform the Development of Electromechanical Systems


Cadence Design Systems, Inc. (Nasdaq: CDNS) and Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced at 3DEXPERIENCE World that they have extended their ongoing strategic

AI, Cybersecurity Skills and Digital Platforms Offer Opportunity for Smaller Businesses According to CITE Research Survey for Dassault Systèmes: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
AI, Cybersecurity Skills and Digital Platforms Offer Opportunity for Smaller Businesses According to CITE Research Survey for Dassault Systèmes


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today revealed the trends that are highlighting opportunities for startups and small and mid-sized businesses to leapfrog larger companies

Dassault Systèmes’ 3DEXPERIENCE World 2024 to Celebrate Imaginations, Innovations and Communities Shaping the Future of Design and Manufacturing: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes’ 3DEXPERIENCE World 2024 to Celebrate Imaginations, Innovations and Communities Shaping the Future of Design and Manufacturing


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced 3DEXPERIENCE World 2024, its annual event dedicated to the 3DEXPERIENCE Works and SOLIDWORKS communities, in Dallas

Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Assystem and Dassault Systèmes Partner to Accelerate the Development of Advanced Modular Reactors: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Assystem and Dassault Systèmes Partner to Accelerate the Development of Advanced Modular Reactors


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Assystem, an international engineering, digital services and project management company, today announced their partnership to accelerate

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Teleperformance Launches Digital Services Arm, TP Infinity, to Better Serve Clients Globally Through Consulting, Design and System Integration Services: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
Teleperformance Launches Digital Services Arm, TP Infinity, to Better Serve Clients Globally Through Consulting, Design and System Integration Services


Teleperformance (Paris:TEP), a global leader in digital business services, today announced the launch of its global digital consulting arm, TP Infinity, designed to deliver a holistic approach to

Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
MEDITWIN Brings Together French Science and Technology Excellence Around Virtual Twins for the Future of Medical Care: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
MEDITWIN Brings Together French Science and Technology Excellence Around Virtual Twins for the Future of Medical Care


The MEDITWIN consortium was announced on December 11, 2023, in the presence of French President Emmanuel Macron. More details were presented at the PariSanté Campus on December 14 in the presence

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL